期刊文献+

非洛地平缓释片在中国高血压患者治疗中的应用 被引量:26

Application of felodipine sustained-release tablets in the hypertension treatment in China
下载PDF
导出
摘要 背景:非洛地平缓释片每日仅需服用1次,具有平坦的血浆-浓度曲线,且起效平稳、口服吸收度好,生物利用度高,患者的依从性好。目的:介绍非洛地平缓释片在国内高血压治疗中的应用状况。方法:应用计算机检索CNKI中国期刊全文数据库,纳入文献时间限定为2005-01-01/2016-07-01。在题名中检索包含"非洛地平缓释片,高血压"的文献,得到174篇;检索主题包含"非洛地平缓释片,材料"的文献,得到22篇,均为中文。按纳入排除标准选择30篇文献进行分析。结果与结论:非洛地平缓释片在国内高血压治疗中已经得到了广泛的应用,尤其是对轻中度原发性高血压的降压效果良好,其疗效与硝苯地平缓释片、美托洛尔缓释片及贝那普利片等降压药相似。非洛地平缓释片的主要不良反应有头痛、面部潮红、心悸、踝部水肿等,但一般都很轻微。对于非洛地平缓释片单药控制不良的高血压患者,可随机联合β受体阻滞剂、血管紧张素转换酶抑制剂、利尿剂等不同类型降压药,同样能够获得较好的降压效果。复方非洛地平缓释片目前也已经在临床上应用,数个多中心双盲随机对照试验已经证实了复方非洛地平缓释片的降压有效性及安全性,对于单药治疗效果不佳的原发性高血压患者,复方非洛地平缓释片也是一个可选的治疗方案。 BACKGROUND:Felodipine sustained-release tablets are taken oral y once daily, which not only exhibit a flat plasma-concentration curve, but also have characteristics of stable effect-acting, good absorption in vivo, high bioavailability and good compliance. OBJECTIVE:To introduce the application status of felodipine sustained-release tablets in the hypertensive treatment of China. METHODS:A computer-based research of CNKI database was performed for literatures published from January 1, 2005 to July 1, 2016. Using the keywords of“felodipine sustained-release tablets, hepertension”, 174 articles were retrieved;and when retrieving“felodipine sustained-release tablets, materials”, 22 were obtained. Thirty literatures were enrol ed final y for analysis according to the exclusion criteria. RESULTS AND CONCLUSION:Felodipine sustained-release tablets have been popularized to the hypertensive treatment in our country, and obtain satisfactory treatment outcomes for mild and moderate spontaneous hepertension, which are similar with those of the nifedipine sustained-release tablets, metoprolol sustained-release tablets and benazepril hydrochloride tablets. Felodipine sustained-release tablets also induce slight adverse reactions, such as headache, flush, palpation and swel ing of ankles. For patients with hypertension cannot be al eviated through single use of felodipine sustained-release tablets, combination with other types of antihypertensive drugs including beta blockers, angiotensin converting enzyme inhibitors and diuretics is advisable. Compound felodipine sustained-release tablets have been used in clinic, and numerous multicenter, double-blind, randomized control trials have proved its effectiveness and safety. Therefore, compound felodipine sustained-release tablets are another choice when single treatment shows no improvement on patients with spontaneous hypertension.
作者 邬瑾
机构地区 武汉大学医院
出处 《中国组织工程研究》 CAS 北大核心 2016年第47期7127-7132,共6页 Chinese Journal of Tissue Engineering Research
关键词 生物材料 缓释材料 非洛地平缓释片 高血压 不良反应 ,Felodipine Delayed-Action Preparations Hypertension Tissue Engineering
  • 相关文献

参考文献22

二级参考文献143

共引文献375

同被引文献136

引证文献26

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部